These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10466859)

  • 21. Correlation between serum cytokeratin 19 fragment and tissue polypeptide antigen levels in patients with non-small cell lung cancer.
    Kashiwabara K; Nakamura H; Kiguchi T; Yagyu H; Kishi K; Wei BR; Yoneyama K; Matsuoka K
    Clin Chim Acta; 1997 Oct; 266(2):149-55. PubMed ID: 9437543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results?
    Plebani M; Basso D; Navaglia F; De Paoli M; Tommasini A; Cipriani A
    Br J Cancer; 1995 Jul; 72(1):170-3. PubMed ID: 7541234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of diffuse pulmonary metastasis of malignant pleural mesothelioma with elevated CYFRA in serum and pleural effusion].
    Saito K; Koyama N; Tanaka M; Usui H; Tojou N; Miyasato I; Marushige F; Inase N; Ichioka M
    Nihon Naika Gakkai Zasshi; 1998 Oct; 87(10):2084-5. PubMed ID: 9867019
    [No Abstract]   [Full Text] [Related]  

  • 24. Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients.
    Pujol JL; Boher JM; Grenier J; Quantin X
    Lung Cancer; 2001; 31(2-3):221-31. PubMed ID: 11165401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnostic value of tissue polypeptide antigen in pleural effusions with malignant pleural mesothelioma].
    Tokuyama T; Yoneda T; Hamada K; Yoshikawa M; Fu A; Tomoda K; Nakaya M; Narita N; Tamura M; Kitamura K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Jan; 33(1):39-43. PubMed ID: 7699966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
    Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
    Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of Cyfra 21-1, TPA, and SCC-Ag in predicting extracervical disease and prognosis in cervical cancer.
    Gaarenstroom KN; Bonfrer JM; Korse CM; Kenter GG; Kenemans P
    Anticancer Res; 1997; 17(4B):2955-8. PubMed ID: 9329574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of desmoplastic malignant mesothelioma with elevated serum CYFRA 21-1].
    Nakamura H; Kitada O; Aragane K; Miyata S; Kodama T; Kuribayashi K; Nakagomi T; Takenaka N; Jin S; Nagasawa M; Sugita M
    Nihon Kokyuki Gakkai Zasshi; 2002 Apr; 40(4):337-40. PubMed ID: 12096506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between serum cytokeratin 19 fragment and tissue polypeptide antigen levels in patients with non-malignant diseases.
    Kashiwabara K; Nakamura H; Kiguchi T; Matsuoka T
    Clin Chim Acta; 1998 May; 273(1):35-42. PubMed ID: 9620468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor markers in pleural effusions.
    Topolcan O; Holubec L; Polivkova V; Svobodova S; Pesek M; Treska V; Safranek J; Hajek T; Bartunek L; Rousarova M; Finek J
    Anticancer Res; 2007; 27(4A):1921-4. PubMed ID: 17649796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring of therapy in inoperable lung cancer patients by measurement of CYFRA 21-1, TPA- TP CEA, and NSE.
    Ebert W; Hoppe M; Muley T; Drings P
    Anticancer Res; 1997; 17(4B):2875-8. PubMed ID: 9329552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of biomarkers SMRP, CA125, and CYFRA 21-1 as potential tumor markers for malignant mesothelioma and lung cancer in a cohort of workers formerly exposed to asbestos.
    Gube M; Taeger D; Weber DG; Pesch B; Brand P; Johnen G; Müller-Lux A; Gross IM; Wiethege T; Weber A; Raithel HJ; Kraus T; Brüning T
    Arch Toxicol; 2011 Mar; 85(3):185-92. PubMed ID: 20737138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions.
    Salama G; Miédougé M; Rouzaud P; Mauduyt MA; Pujazon MC; Vincent C; Carles P; Serre G
    Br J Cancer; 1998; 77(3):472-6. PubMed ID: 9472646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative CYFRA 21-1 level as a prognostic indicator in resected nonsmall cell lung cancer.
    Niklinski J; Burzykowski T; Niklinska W; Laudanski J; Chyczewski L; Rapellino M; Furman M
    Eur Respir J; 1998 Dec; 12(6):1424-8. PubMed ID: 9877503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical value of CYFRA 21.1, carcinoembryonic antigen, neurone-specific enolase, tissue polypeptide specific antigen and tissue polypeptide antigen in the diagnosis of lung cancer.
    Bates J; Rutherford R; Divilly M; Finn J; Grimes H; O'Muircheartaigh I; Gilmartin JJ
    Eur Respir J; 1997 Nov; 10(11):2535-8. PubMed ID: 9426091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased CYFRA 21-1 and CEA levels are negative predictors of outcome in p-stage I NSCLC.
    Muley T; Dienemann H; Ebert W
    Anticancer Res; 2003; 23(5b):4085-93. PubMed ID: 14666606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tissue polypeptide antigen as a biological marker of malignant pleural mesothelioma].
    Tokuyama T; Okamoto Y; Hamada K; Yoneda T; Narita N; Tamura M; Kitamura K; Maruyama H; Takezawa Y; Yamada Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jun; 35(6):609-15. PubMed ID: 9294293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p27 immunostaining is related to prognosis in malignant mesothelioma.
    Beer TW; Shepherd P; Pullinger NC
    Histopathology; 2001 Jun; 38(6):535-41. PubMed ID: 11422497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphological aspects as prognostic factors in malignant mesothelioma: a study of 58 cases.
    Motta AB; Pinheiro G; Antonângelo L; Parra ER; Monteiro MM; Pereira JC; Takagaki T; Terra Filho M; Martins S; Capelozzi VL
    J Bras Pneumol; 2006; 32(4):322-32. PubMed ID: 17268732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue polypeptide antigen (TPA) in pleural effusions.
    Parazzi F; Faravelli B; Gallo L; Nosenzo M; Razzetti A; Barone D; Bandelloni R; D'Amore E
    Tumori; 1987 Feb; 73(1):33-6. PubMed ID: 2435037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.